This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovative Contributions of Takeo Kawabata
Introduction: Takeo Kawabata, a distinguished inventor based in Sagamihara, Japan, has made significant contributions to the field of pharmaceutical chemistry. With one notable patent to his name, Kawabata has showcased his expertise in the synthesis of heterocyclic compounds that are vital in developing valuable medicinal products.
Latest Patents: The patent held by Takeo Kawabata is focused on heterocyclic compounds and their production. The specific compound described in the patent features a complex formula where R1, R2, R3, and R4 can vary as hydrogen atoms, lower alkyl groups, ar(lower)alkyl groups, or aryl groups. Additionally, R1 and R2 may be combined to form a lower alkylene group, as well as R3 and R4. The flexibility in the structure also allows for configurations that include an o-phenylene group. This innovation plays a critical role as an intermediate in synthesizing 1β-methylcarbapenem compounds, which are recognized for their valuable antibacterial properties.
Career Highlights: Kawabata is currently employed at Sumitomo Pharmaceuticals Company Limited, a renowned entity in pharmaceutical research and development. His work largely focuses on advancing the field through innovative solutions that address pressing medical challenges.
Collaborations: Throughout his career, Takeo has collaborated with fellow researchers such as Shiro Terashima and Yoshio Ito. These partnerships exemplify the collaborative spirit in scientific research, where combined expertise leads to productive advancements and innovative breakthroughs in medical science.
Conclusion: Takeo Kawabata's innovative work in the synthesis of heterocyclic compounds is a testament to his dedication to advancing pharmaceutical sciences. His contributions are invaluable, particularly in developing antibiotics that can combat resistant bacteria, thus improving healthcare outcomes. As his career progresses, the scientific community eagerly anticipates further contributions from this talented inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile